Peter Benson

(Mr. Peter Benson)

Currently holds positions in Ascelia Pharma AB, Arcoma AB and Alligator Bioscience AB

Performance

4.2
Average Return

-12.5%

30 Days

8.2%

90 Days

15.1%

120 Days
Success Rate

50%

30 Days

68%

90 Days

82%

120 Days

Positions

Position Company Period
Chairman of the Board Ascelia Pharma AB Jan. 1, 2017 -
Director Arcoma AB Jan. 1, 2010 -
Independent Chairman of the Board Alligator Bioscience AB Jan. 1, 2014 -
Director Alligator Bioscience AB Jan. 1, 2011 - Jan. 1, 2014
Peter Benson's trades of Ascelia Pharma AB's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-23 2024-02-23 B Purchase
8,279
7.50
SEK 5,998
8,279 7.50 SEK 62,093
2024-02-10 2024-02-09 B Purchase
5,255
8.79
SEK 4,402
5,255 8.79 SEK 46,191
2024-01-08 2024-01-08 B Purchase
10,000
5.85
SEK 5,698
10,000 5.85 SEK 58,500
2024-01-08 2024-01-08 B Purchase
5,000
5.84
SEK 2,842
5,000 5.84 SEK 29,183
2024-01-08 2024-01-08 B Purchase
5,000
5.84
SEK 2,844
5,000 5.84 SEK 29,200
2023-01-20 2023-01-20 B Purchase
3,042
13.86
SEK 4,081
3,042 13.86 SEK 42,162
2023-01-20 2023-01-20 B Purchase
1,958
14.08
SEK 2,669
1,958 14.08 SEK 27,569
2023-01-20 2023-01-20 B Purchase
5,000
13.86
SEK 6,708
5,000 13.86 SEK 69,300
2022-12-14 2022-12-12 B Purchase
5,000
15.48
SEK 7,964
5,000 15.48 SEK 77,400
2022-12-06 2022-12-06 B Purchase
325
17.20
SEK 575
325 17.20 SEK 5,590
2022-12-06 2022-12-06 B Purchase
500
17.34
SEK 892
500 17.34 SEK 8,670
2022-12-06 2022-12-06 B Purchase
10,500
17.32
SEK 18,712
10,500 17.32 SEK 181,860
2022-02-14 2022-02-14 B Purchase
1,400
24.80
SEK 3,572
1,400 24.80 SEK 34,720
2022-02-14 2022-02-14 B Purchase
2,500
24.75
SEK 6,367
2,500 24.75 SEK 61,875
// ... existing code ...